A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.
Jonathan L MettsBrittany HarringtonEmad SalmanScott M BradfieldJennifer FlanaryMaua MoshaErnest AmankwahStacie StapletonPublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2022)
gov ).
Keyphrases